MegaPro Biomedical Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 20

Employees

  • Stock Symbol
  • 6827

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.59
  • (As of Friday Closing)

MegaPro Biomedical General Information

Description

MegaPro Biomedical Co Ltd is a nanomedicine development company. The Company's only reportable operating segment is the Drug Application Development segment, which is engaged in the development of nano-iron oxide IOP drugs.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Suite 526, Bldg.52, No.195, Sec.4
  • Chung Hsing Rd
  • Hsinchu, 310-40
  • Taiwan
+886 03
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
ROCO
Corporate Office
  • Suite 526, Bldg.52, No.195, Sec.4
  • Chung Hsing Rd
  • Hsinchu, 310-40
  • Taiwan
+886 03

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MegaPro Biomedical Stock Performance

As of 20-Nov-2026, MegaPro Biomedical’s stock price is $0.59. Its current market cap is $71M with 121M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.59 $0.70 $0.29 - $0.73 $71M 121M 721K -$0.04

MegaPro Biomedical Financials Summary

As of 30-Jun-2026, MegaPro Biomedical has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 27,286 30,050 23,300 46,927
Revenue 0 0 1 1
EBITDA (2,970) (3,420) (4,735) (3,716)
Net Income (3,279) (3,818) (5,112) (4,095)
Total Assets 7,325 8,919 6,821 9,587
Total Debt 46 92 172 271
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MegaPro Biomedical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MegaPro Biomedical‘s full profile, request access.

Request a free trial

MegaPro Biomedical Patents

MegaPro Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024432366-A1 Iron-oxide nanoparticle-loaded mesenchymal stem cells and uses thereof Pending 04-Mar-2024
WO-2025184767-A1 Iron-oxide nanoparticle-loaded mesenchymal stem cells and uses thereof Pending 04-Mar-2024
WO-2025184767-A8 Iron-oxide nanoparticle-loaded mesenchymal stem cells and uses thereof Pending 04-Mar-2024
AU-2019446285-A1 Pharmaceutical compositions containing mixed polymeric micelles Active 16-May-2019
AU-2019446285-B2 Pharmaceutical compositions containing mixed polymeric micelles Active 16-May-2019 A61K9/1075
To view MegaPro Biomedical’s complete patent history, request access »

MegaPro Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MegaPro Biomedical Investments (1)

MegaPro Biomedical’s most recent deal was a Joint Venture with JV Trium Therapeutics (CCPC/ MegaPro / Wellbridge). The deal was made on 14-Jul-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
JV Trium Therapeutics (CCPC/ MegaPro / Wellbridge) 14-Jul-2022 Joint Venture Drug Discovery
To view MegaPro Biomedical’s complete investments history, request access »

MegaPro Biomedical ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view MegaPro Biomedical’s complete esg history, request access »

MegaPro Biomedical FAQs

  • When was MegaPro Biomedical founded?

    MegaPro Biomedical was founded in 2014.

  • Where is MegaPro Biomedical headquartered?

    MegaPro Biomedical is headquartered in Hsinchu, Taiwan.

  • What is the size of MegaPro Biomedical?

    MegaPro Biomedical has 20 total employees.

  • What industry is MegaPro Biomedical in?

    MegaPro Biomedical’s primary industry is Drug Discovery.

  • Is MegaPro Biomedical a private or public company?

    MegaPro Biomedical is a Public company.

  • What is MegaPro Biomedical’s stock symbol?

    The ticker symbol for MegaPro Biomedical is 6827.

  • What is the current stock price of MegaPro Biomedical?

    As of 20-Nov-2026 the stock price of MegaPro Biomedical is $0.59.

  • What is the current market cap of MegaPro Biomedical?

    The current market capitalization of MegaPro Biomedical is $71M.

  • What is MegaPro Biomedical’s annual earnings per share (EPS)?

    MegaPro Biomedical’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process